These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32181826)

  • 21. Health System and Beneficiary Costs Associated With Intensive End-of-Life Medical Services.
    Gidwani-Marszowski R; Asch SM; Mor V; Wagner TH; Faricy-Anderson K; Illarmo S; Hsin G; Patel MI; Ramchandran K; Lorenz KA; Needleman J
    JAMA Netw Open; 2019 Sep; 2(9):e1912161. PubMed ID: 31560384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicaid Expenditures for Fee-for-Service Enrollees with Behavioral Diagnoses: Findings from a 50 State Claims Analysis.
    Ward MC; Lally C; Druss BG
    Community Ment Health J; 2017 Jan; 53(1):1-7. PubMed ID: 27306989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer's next frontier: addressing high and increasing costs.
    Elkin EB; Bach PB
    JAMA; 2010 Mar; 303(11):1086-7. PubMed ID: 20233828
    [No Abstract]   [Full Text] [Related]  

  • 24. Realigning reimbursement policy and financial incentives to support patient-centered out-of-hospital care.
    Munjal K; Carr B
    JAMA; 2013 Feb; 309(7):667-8. PubMed ID: 23423411
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased Medicare expenditures for physicians' services: what are the causes?
    Buntin MJ; Escarcé JJ; Goldman D; Kan H; Laugesen MJ; Shekelle P
    Inquiry; 2004; 41(1):83-94. PubMed ID: 15224962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accountable care organizations and evidence-based payment reform.
    McClellan M
    JAMA; 2015 Jun; 313(21):2128-2130. PubMed ID: 25938803
    [No Abstract]   [Full Text] [Related]  

  • 27. Pioneer accountable care organizations: traversing rough country.
    Casalino LP
    JAMA; 2015 Jun; 313(21):2126-7. PubMed ID: 25938759
    [No Abstract]   [Full Text] [Related]  

  • 28. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.
    Colby MS; Lipson DJ; Turchin SR
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S51-60. PubMed ID: 22476794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
    Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
    Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capitation, managed care, and chronic obstructive pulmonary disease.
    Grasso ME; Weller WE; Shaffer TJ; Diette GB; Anderson GF
    Am J Respir Crit Care Med; 1998 Jul; 158(1):133-8. PubMed ID: 9655719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A solo practitioner's experience with MIPS.
    Ryan PC; Johnson B; Rathbun J; Woo K
    J Vasc Surg; 2018 Nov; 68(5):1607. PubMed ID: 30360850
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of home-based, patient-centered support for people with advanced illness in an open health system: A retrospective claims analysis of health expenditures, utilization, and quality of care at end of life.
    Sudat SEK; Franco A; Pressman AR; Rosenfeld K; Gornet E; Stewart W
    Palliat Med; 2018 Feb; 32(2):485-492. PubMed ID: 28590150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accessing your Quality Payment Program feedback reports.
    Smith TA; Ryan P; Shireman PK; Rathbun J; Woo K
    J Vasc Surg; 2018 Dec; 68(6):1954. PubMed ID: 30470374
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of payor/provider type on health care use and expenditures among the frail elderly.
    Experton B; Li Z; Branch LG; Ozminkowski RJ; Mellon-Lacey DM
    Am J Public Health; 1997 Feb; 87(2):210-6. PubMed ID: 9103099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical Aid service overuse assessed by case managers in Korea.
    Shin SM; Kim MJ; Kim ES; Lee HW; Park CG; Kim HK
    J Adv Nurs; 2010 Oct; 66(10):2257-65. PubMed ID: 20626489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between ex ante mortality risk and end-of-life medical costs.
    Howard DH; Culler SD; Druss BG; Thorpe KE
    Appl Health Econ Health Policy; 2006; 5(1):37-44. PubMed ID: 16774291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of healthcare expenditures with aggressive versus palliative care for cancer patients at the end of life: a cross-sectional study using claims data in Japan.
    Morishima T; Lee J; Otsubo T; Imanaka Y
    Int J Qual Health Care; 2014 Feb; 26(1):79-86. PubMed ID: 24225269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow the money.
    Dimmitt BS
    State Health Care Am; 1996; ():6-14. PubMed ID: 10539293
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse selection among multiple competing health maintenance organizations.
    Robinson JC; Gardner LB
    Med Care; 1995 Dec; 33(12):1161-75. PubMed ID: 7500657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.